1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow SYNSORB Pk: new trials by email Literature Review of SYNSORB Pk trials Research Report on SYNSORB Pk
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome SYNSORB Pk, Placebo - Hemolytic Uremic Syndrome | Phase 3 | Terminated | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 145 | 1997-07-27 | 2017-06-01 |
Bacterial Infections (1) · Communicable Diseases (1) · Escherichia coli Infections (1) · Hemolytic-Uremic Syndrome (1) · Immune System Diseases (1) · Rare Diseases (1) · Urogenital Diseases (1)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)
Canada (1) · United States (1)
Howard Trachtman (1)
PMID 12966125, PMID 34219224, PMID 40277027
R01DK052147 (1)